Data gathered: September 7
Alternative Data for LabCorp
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 1,582 | Sign up | Sign up | Sign up | |
Sentiment | 100 | Sign up | Sign up | Sign up | |
Webpage traffic | 13,101,000 | Sign up | Sign up | Sign up | |
Employee Rating | 70 | Sign up | Sign up | Sign up | |
Google Trends | 29 | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 74 | Sign up | Sign up | Sign up | |
Facebook Followers | 13,670 | Sign up | Sign up | Sign up | |
Instagram Followers | 9,980 | Sign up | Sign up | Sign up | |
Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Mentions | 1 | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 2,047 | Sign up | Sign up | Sign up | |
Twitter Followers | 7,923 | Sign up | Sign up | Sign up | |
Twitter Mentions | 10 | Sign up | Sign up | Sign up | |
Youtube Subscribers | 5,940 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | 30 | Sign up | Sign up | Sign up | |
Business Outlook | 60 | Sign up | Sign up | Sign up | |
Linkedin Employees | 37,262 | Sign up | Sign up | Sign up |
About LabCorp
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries.
![LabCorp](https://altindex.com/assets/images/tickers/LH.jpg)
Price | $223.91 |
Target Price | Sign up |
Volume | 488,210 |
Market Cap | $19.1B |
Year Range | $191.9 - $235.26 |
Dividend Yield | 1.27% |
PE Ratio | 42.18 |
Industry | Health Care Services |
In the news
![]() |
Laboratory Co. of America Holdings (NYSE:LH) Shares Bought by Van ECK Associates CorpSeptember 6 - ETF Daily News |
Investors in Labcorp Holdings (NYSE:LH) have seen favorable returns of 59% over the past five yearsSeptember 5 - Yahoo |
|
![]() |
Panagora Asset Management Inc. Has $520,000 Stake in Laboratory Co. of America Holdings (NYSE:LH)September 4 - ETF Daily News |
![]() |
Resonant Capital Advisors LLC Raises Position in Laboratory Co. of America Holdings (NYSE:LH)September 3 - ETF Daily News |
![]() |
Laboratory Co. of America Holdings (NYSE:LH) Sees Large Decrease in Short InterestSeptember 3 - ETF Daily News |
![]() |
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Has $937,000 Holdings in Laboratory Co. of America Holdings (NYSE:LH)September 2 - ETF Daily News |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q2 '24 | 3.22B | 2.29B | 926M | 205M | 377M | 3.940 |
Q1 '24 | 3.18B | 2.28B | 897M | 228M | 404M | 3.680 |
Q4 '23 | 3.03B | 2.21B | 821M | -167M | -32M | 3.300 |
Q3 '23 | 3.06B | 2.21B | 851M | 183M | 344M | 3.380 |
Q2 '23 | 3.03B | 2.19B | 842M | 189M | 340M | 3.800 |
Insider Transactions View All
EISENBERG GLENN A filed to sell 40,360 shares at $223.6. August 19 '24 |
EISENBERG GLENN A filed to sell 43,310 shares at $222.6. August 19 '24 |
EISENBERG GLENN A filed to sell 31,289 shares at $224.5. August 19 '24 |
ANDERSON KERRII B filed to sell 14,722 shares at $225. August 9 '24 |
ANDERSON KERRII B filed to sell 15,308 shares at $225. August 9 '24 |
Similar companies
Congress Trading View All
Politician | Filing Date | Type | Size |
---|---|---|---|
John James |
Sep 2, 24 | Buy | $1K - $15K |
Ro Khanna |
Jul 8, 24 | Buy | $1K - $15K |
Rohit Khanna Democrat |
Jun 5, 24 | Buy | $1K - $15K |
Read more about LabCorp (LH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of LabCorp?
The Market Cap of LabCorp is $19.1B.
What is LabCorp's PE Ratio?
As of today, LabCorp's PE (Price to Earnings) ratio is 42.18.
What is the current stock price of LabCorp?
Currently, the price of one share of LabCorp stock is $223.91.
How can I analyze the LH stock price chart for investment decisions?
The LH stock price chart above provides a comprehensive visual representation of LabCorp's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling LabCorp shares. Our platform offers an up-to-date LH stock price chart, along with technical data analysis and alternative data insights.
Does LH offer dividends to its shareholders?
Yes, LabCorp (LH) offers dividends to its shareholders, with a dividend yield of 1.27%. This dividend yield represents LabCorp's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering LabCorp in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of LabCorp?
Some of the similar stocks of LabCorp are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.